CorVel Corporation
$88.28+$0.92 (+1.1%)
Last close · Data as of Nov 20, 2026
- Market cap
- $3.0B
- P/E
- 27.2x
- EV / EBITDA
- 16.0x
- Revenue
- $958.5M
- Net margin
- 11.5%
- ROCE
- 34.5%
Price chart
Technical chartScreen technicals →+23.1% over the last year
Daily closes.
Go deeper
Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes
Performance
Price return, before dividends, to the 20 Nov 2026 close.
- 1M
- +8.6%
- 3M
- +25.7%
- 6M
- +37.4%
- 1Y
- +23.1%
- 5Y
- +35.6%
52-week range
Day change +$0.92 (+1.1%) from $87 to $88 · Last close Nov 20, 2026
Best weekday to invest, historically
The same weekly amount in CRVL, bought on each weekday since 2021.
News & filings
What CorVel filed, who traded, and what's next
How to read this
"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.
AI Summary
US StockStrengthReturn on capital employed of 34.5%.
Concerns (1)
- Net margin of 11.5% against a peer median of 25.3%.
Prices to the 20 Nov 2026 close · Financial year: fiscal 2026
Rule-based from financial data. Not advice.
About the company
CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.
Read moreShow less
CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.
- Sector
- Financial Services
- Shares outstanding
- 50.9M
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- $3.0B
- P/E
- 27.2x
- P/B
- 7.6x
- EV / EBITDA
- 16.0x
- EV / Sales
- 2.9x
- P/S
- 3.1x
- 52-week high
- $88.87
- 52-week low
- $46.00
Profitability
- Operating margin
- 14.9%
- Net margin
- 11.5%
- EBITDA margin
- 18.2%
- ROE
- 28.0%
- ROCE
- 34.5%
- ROA
- 17.2%
- Asset turnover
- 1.49
Growth
- RevenueFY2026, the latest fiscal year in the company's growth history.
- $958.5M
- Revenue growth, 1YFY2026, the latest fiscal year in the company's growth history.
- 7.0%
- Revenue CAGR, 3YFY2026, the latest fiscal year in the company's growth history.
- 10.1%
- Net profit growth, 1YFY2026, the latest fiscal year in the company's growth history.
- 16.0%
- Free cash flowFY2026, the latest fiscal year in the company's growth history.
- $110.3M
Solvency
- Current ratio
- 2.03
- Debt / Equity
- 0.07
- Debt / Assets
- 0.04
- CFO / Net profit
- 1.41
- Cash / Market cap
- 7.8%
Where the revenue went
Of every $100 of FY2026 revenue, $12 was left as net income.
| From | To | Amount |
|---|---|---|
| Revenue | Cost of revenue | $725.7M |
| Revenue | Gross profit | $232.9M |
| Gross profit | Selling, general and administrative | $89.7M |
| Gross profit | Other operating expenses | $10.0k |
| Gross profit | Operating income | $143.1M |
| Operating income | Pretax income | $143.1M |
| Pretax income | Tax and other | $32.8M |
| Pretax income | Net income | $110.3M |
Revenue and net profit
Revenue grew 7.0% in FY2026; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2023 | $718.6M | $66.4M |
| FY2024 | $795.3M | $76.3M |
| FY2025 | $895.6M | $95.2M |
| FY2026 | $958.5M | $110.3M |
Cash flows
FY2026: $155.6M from operations, $110.3M free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2023 | $82.3M | $56.0M |
| FY2024 | $99.2M | $70.0M |
| FY2025 | $127.3M | $91.6M |
| FY2026 | $155.6M | $110.3M |
Growth
Latest fiscal year 2026: each figure with its change over the year before.
- Revenue
- $958.5M+7.0%1Y
- EBITDA
- $174.9M+16.3%1Y
- Net profit
- $110.3M+16.0%1Y
- Cash from operations
- $155.6M+22.2%1Y
- Free cash flow
- $110.3M+20.4%1Y
- Revenue CAGR, 3Y
- 10.1%
- Net profit CAGR, 3Y
- 18.5%
| Year | Revenue | EBITDA | Net profit | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|
| FY2026 | $958.5M | $174.9M | $110.3M | $110.3M | 28.0% | +7.0% | +16.0% |
Monthly returns
Month-by-month returns of CRVL across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2026.
| Line | FY2026 |
|---|---|
| Assets | $643.0M |
| Current assets | $462.3M |
| Non-current assets | $180.7M |
| Liabilities | $248.8M |
| Current liabilities | $228.1M |
| Non-current liabilities | $20.7M |
| Equity | $394.2M |
| Paid-in capital | $268.5M |
| Retained earnings | $1.0B |
| Treasury stock | $887.7M |
Market cap against peers
8 peers: same sector, nearest by size.
Peers map
Financial Services companies placed by value, growth and quality; CRVL highlighted.
P/E against peers
CRVL trades at 27.2x earnings against a peer median of 13.9x (a 96% premium).
Not shown (no positive earnings and no EV / Sales): Simmons First National Corporation.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| CorVel CorporationCRVLthis companyP/E ↑ premium | $3.0B | 27.2x | 7.6x | 28.0% | 16.0x |
| First Financial Bancorp.FFBC | $3.2B | 12.5x | 1.2x | 9.2% | — |
| Park National CorporationPRK | $3.1B | 17.4x | 2.3x | 13.3% | — |
| Simmons First National CorporationSFNC | $3.1B | -7.9x | 0.9x | -11.6% | — |
| Bank of Hawaii CorporationBOH | $3.0B | 14.7x | 2.0x | 13.7% | — |
| Banc of California, Inc.BANC | $3.0B | 13.0x | 1.0x | 7.5% | — |
| Seacoast Banking Corporation of FloridaSBCF | $2.9B | 20.3x | 1.1x | 5.3% | — |
| Provident Financial Services, Inc.PFS | $2.9B | 10.0x | 1.0x | 10.3% | — |
| WisdomTree, Inc.WT | $2.9B | 26.8x | 7.0x | 26.2% | 19.3x |
| Peer median | — | 13.9x | 1.1x | 9.8% | 19.3x |
Year-to-date ROI
CRVL since 1 January, against earlier years.
Historical volatility
CRVL's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.
Consolidated figures in USD, fiscal years, newest first.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2023 | 11.8% |
| FY2024 | 12.0% |
| FY2025 | 13.5% |
| FY2026 | 14.9% |
| Line | FY2026 |
|---|---|
| RevenueTotal Revenue | $958.5M |
| Cost of revenueCost Of Revenue | $725.7M |
| Gross profitGross Profit | $232.9M |
| Operating expensesOperating Expense | $89.7M |
| Selling, general and administrativeSelling General And Administration | $89.7M |
| Total expensesTotal Expenses | $815.4M |
| Operating incomeOperating Income | $143.1M |
| Pretax incomePretax Income | $143.1M |
| TaxTax Provision | $32.8M |
| Net incomeNet Income | $110.3M |
| Per share | |
| Supplementary |
| Line | FY2026 |
|---|---|
| AssetsTotal Assets | $643.0M |
| Current assetsCurrent Assets | $462.3M |
| Non-current assetsTotal Non Current Assets | $180.7M |
| LiabilitiesTotal Liabilities Net Minority Interest | $248.8M |
| Current liabilitiesCurrent Liabilities | $228.1M |
| Non-current liabilitiesTotal Non Current Liabilities Net Minority Interest | $20.7M |
| EquityTotal Equity Gross Minority Interest | $394.2M |
| Supplementary |
| Line | FY2026 |
|---|---|
| Operating cash flowOperating Cash Flow | $155.6M |
| Cash from continuing operationsCash Flow From Continuing Operating Activities | $155.6M |
| Net income, continuing operationsNet Income From Continuing Operations | $110.3M |
| Depreciation and amortisationDepreciation And Amortization | $31.8M |
| Depreciation, amortisation and depletionDepreciation Amortization Depletion | $31.8M |
| Depreciation | $31.6M |
| Amortization cash flowAmortization Cash Flow | $180.0k |
| Amortization of intangiblesAmortization Of Intangibles | $180.0k |
| Stock-based compensationStock Based Compensation | $5.4M |
| Deferred taxDeferred Tax | $4.8M |
| Deferred income taxDeferred Income Tax | $4.8M |
| Asset impairmentAsset Impairment Charge | $710.0k |
| Provision and write off of assetsProvisionand Write Offof Assets | $120.0k |
| Change in working capitalChange In Working Capital | $2.5M |
| Investing cash flowInvesting Cash Flow | -$45.4M |
| Cash from continuing investingCash Flow From Continuing Investing Activities | -$45.4M |
| Capital expenditureCapital Expenditure | -$45.4M |
| Purchase of PP&EPurchase Of PPE | -$45.4M |
| Net PP&E purchases and salesNet PPE Purchase And Sale | -$45.4M |
| Financing cash flowFinancing Cash Flow | -$47.8M |
| Cash from continuing financingCash Flow From Continuing Financing Activities | -$47.8M |
| Net common stock issuedNet Common Stock Issuance | -$56.2M |
| Common stock repurchasedCommon Stock Payments | -$56.2M |
| Share buybacksRepurchase Of Capital Stock | -$56.2M |
| Stock options exercisedProceeds From Stock Option Exercised | $8.4M |
| Change in cashChanges In Cash | $62.5M |
| Cash at the start of the yearBeginning Cash Position | $170.6M |
| Cash at the end of the yearEnd Cash Position | $233.1M |
| Free cash flowFree Cash Flow | $110.3M |
| Supplemental |
Learn while you research
Academy chapters picked for CorVel Corporation and the metrics on this page.
- 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 02 Sector AnalysisBanks & financials are uniquely sensitive to rates and credit cycles.6 min read
- 03 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
- 04 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read